Conditions sufficient for nonsynaptic epileptogenesis in the CA1 region of hippocampal slices

J Neurophysiol. 2002 Jan;87(1):62-71. doi: 10.1152/jn.00196.2001.

Abstract

Nonsynaptic mechanisms exert a powerful influence on seizure threshold. It is well-established that nonsynaptic epileptiform activity can be induced in hippocampal slices by reducing extracellular Ca(2+) concentration. We show here that nonsynaptic epileptiform activity can be readily induced in vitro in normal (2 mM) Ca(2+) levels. Those conditions sufficient for nonsynaptic epileptogenesis in the CA1 region were determined by pharmacologically mimicking the effects of Ca(2+) reduction in normal Ca(2+) levels. Increasing neuronal excitability, by removing extracellular Mg(2+) and increasing extracellular K(+) (6-15 mM), induced epileptiform activity that was suppressed by postsynaptic receptor antagonists [D-(-)-2-amino-5-phosphonopentanoic acid, picrotoxin, and 6,7-dinitroquinoxaline-2,3-dione] and was therefore synaptic in nature. Similarly, epileptiform activity induced when neuronal excitability was increased in the presence of K(Ca) antagonists (verruculogen, charybdotoxin, norepinephrine, tetraethylammonium salt, and Ba(2+)) was found to be synaptic in nature. Decreases in osmolarity also failed to induce nonsynaptic epileptiform activity in the CA1 region. However, increasing neuronal excitability (by removing extracellular Mg(2+) and increasing extracellular K(+)) in the presence of Cd(2+), a nonselective Ca(2+) channel antagonist, or veratridine, a persistent sodium conductance enhancer, induced spontaneous nonsynaptic epileptiform activity in vitro. Both novel models were characterized using intracellular and ion-selective electrodes. The results of this study suggest that reducing extracellular Ca(2+) facilitates bursting by increasing neuronal excitability and inhibiting Ca(2+) influx, which might, in turn, enhance a persistent sodium conductance. Furthermore, these data show that nonsynaptic mechanisms can contribute to epileptiform activity in normal Ca(2+) levels.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cadmium / pharmacology
  • Calcium / metabolism
  • Calcium Channel Blockers / pharmacology
  • Epilepsy / physiopathology*
  • Extracellular Space / metabolism
  • Hippocampus / cytology
  • Hippocampus / drug effects
  • Hippocampus / physiopathology*
  • In Vitro Techniques
  • Membrane Potentials / drug effects
  • Neurons / drug effects
  • Neurons / physiology
  • Patch-Clamp Techniques
  • Potassium / metabolism
  • Potassium Channel Blockers / pharmacology
  • Potassium Channels, Calcium-Activated / antagonists & inhibitors
  • Potassium Channels, Calcium-Activated / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Sodium Channels / drug effects
  • Sodium Channels / metabolism
  • Synapses*
  • Synaptic Transmission / drug effects
  • Veratridine / pharmacology

Substances

  • Calcium Channel Blockers
  • Potassium Channel Blockers
  • Potassium Channels, Calcium-Activated
  • Sodium Channels
  • Cadmium
  • Veratridine
  • Potassium
  • Calcium